clofibrate has been researched along with probucol in 72 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 53 (73.61) | 18.7374 |
1990's | 16 (22.22) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (4.17) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allen, BJ; Barnhart, JW; Byers, C; Dull, RG; Mueller, LG; Renzi, AA; Rytter, DJ; Wagner, ER | 1 |
Baader, E; Bartmann, W; Beck, G; Bergmann, A; Granzer, E; Jendralla, H; Kesseler, K; Krause, R; Schacht, U; von Kerekjarto, B | 1 |
Aizawa, Y; Fujita, T; Hasegawa, K; Horikoshi, H; Kanai, T; Kurumada, T; Yoshioka, T | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Barnhart, JW; Molello, JA; Rytter, DJ | 1 |
Avery, GS; Brogden, RN; Heel, RC; Speight, TM | 1 |
Martz, BL | 1 |
Fleischmajer, R | 1 |
Kritchevsky, D | 2 |
Itakura, H | 1 |
Kłosiewicz-Latoszek, L; Szostak, WB | 1 |
Hunninghake, DB | 2 |
Huttunen, JK; Miettinen, TA; Naukkarinen, V; Strandberg, T; Vanhanen, H | 1 |
Dostert, P; Hartmann, R; Oesch, F; Schladt, L; Strolin-Benedetti, M; Timms, C; Wörner, W | 1 |
Islami, Y; Ribeiro, LG | 1 |
Cravanzola, C; Franzone, JS; Pernigotti, ML; Reboani, MC; Torrielli, MV | 1 |
Naito, HK | 1 |
Kurasawa, T; Yamamoto, A; Yokoyama, S | 1 |
Davignon, J | 3 |
Blum, CB; Levy, RI | 1 |
Nikkilä, EA; Tikkanen, MJ | 1 |
Perry, RS | 1 |
Havel, RJ; Kane, JP | 1 |
Malinow, MR | 1 |
Gotto, AM; Jones, PH; Scott, LW | 1 |
Alaupovic, P; Bouthillier, D; Davignon, J; Nestruck, AC | 1 |
Horie, S; Mitsukawa, M; Seki, K; Suga, T; Watanabe, T | 1 |
Funahashi, T; Kishino, B; Matsuzawa, Y; Yamamoto, A; Yamamura, T; Yokoyama, S | 1 |
Davignon, J; Nestruck, AC; Pande, SV | 1 |
Krishnamurthy, A; Shridhar, DR; Thapar, GS | 1 |
de Meglio, P; Gentili, P; Manzardo, S; Ravenna, F; Riva, M | 1 |
Fumagalli, R; Paoletti, R; Sirtori, C | 1 |
Dietschy, JM; Turley, SD | 1 |
Donatelli, L | 1 |
Santafé Oroz, J; Segarra Domènech, J | 1 |
Glueck, C | 1 |
Nash, DT | 1 |
Harvengt, C; Heller, F | 1 |
Kawecka-Jaszcz, K; Kocemba, J; Król, W; Wasowicz, B | 1 |
Ehnholm, C; Huttunen, JK; Kumlin, T; Mattila, S; Miettinen, TA; Naukkarinen, V | 1 |
Abiko, Y; Nakayasu, T; Tawara, K; Tomikawa, M | 1 |
Davignon, J; Dubreuil-Quidoz, S; LeLorier, J; Lussier-Cacan, S | 1 |
LaRosa, JC | 1 |
Baraldi, G; Biso, P; Cavazzini, MG; De Benedittis, G; Labò, G; Melchionda, N; Parenti, M; Pasquali, R; Sorrenti, G | 1 |
Samuel, P | 1 |
Holets, RJ; Kottke, BA; Li, JR | 1 |
Barnard, SD; Caldwell, WJ; LeBeau, JE; Molello, JA | 2 |
Albengres, E; Choisy, H; Millart, H; Tillement, JP | 1 |
Pignard, P | 1 |
Leutenegger, M | 1 |
Shand, JH; West, DW | 3 |
Gotto, AM; Yeshurun, D | 1 |
Gil, MJ; Monreal, JI; Rivero, A | 1 |
Aberg, F; Appelkvist, EL; Dallner, G; Zhang, Y | 1 |
Ades, EW; Lawley, TJ; Pruckler, JM | 1 |
Auwerx, J; Fruchart, JC; Staels, B; Van Tol, A | 1 |
Aragane, K; Kitamine, T; Kusunoki, J; Ohnishi, H; Yamaura, T | 1 |
16 review(s) available for clofibrate and probucol
Article | Year |
---|---|
Probucol: a review of its pharmacological properties and therapeutic use in patients with hypercholesterolaemia.
Topics: Animals; Arteriosclerosis; Clofibrate; Dogs; Humans; Hypercholesterolemia; Hyperlipidemias; Kinetics; Phenols; Probucol; Rats | 1978 |
Newer hypolipidemic compounds.
Topics: Animals; Arteriosclerosis; Cholesterol; Cholesterol, Dietary; Clofibrate; Halofenate; Humans; Hypolipidemic Agents; Probucol; Rabbits; Rats; Structure-Activity Relationship; Triglycerides; Uric Acid | 1975 |
Drug treatment of dyslipoproteinemia.
Topics: Bile Acids and Salts; Clofibrate; Coronary Disease; Drug Therapy, Combination; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemias; Hypolipoproteinemias; Niacin; Probucol | 1990 |
Lipid lowering effects on cardiovascular morbidity and mortality. Clinical evidence and therapeutic guidelines.
Topics: Cholesterol; Cholestyramine Resin; Clinical Trials as Topic; Clofibrate; Coronary Disease; Follow-Up Studies; Gemfibrozil; Humans; Hypolipidemic Agents; Lipoproteins; Male; Probucol; Triglycerides | 1988 |
Reducing cardiac deaths with hypolipidemic drugs.
Topics: Cholesterol; Cholestyramine Resin; Clofibrate; Colestipol; Coronary Disease; Feeding Behavior; Gemfibrozil; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipids; Lipoproteins, LDL; Niacin; Patient Education as Topic; Pentanoic Acids; Probucol | 1987 |
Contemporary recommendations for evaluating and treating hyperlipidemia.
Topics: Clofibrate; Dextrothyroxine; Gemfibrozil; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipids; Lipoproteins; Lovastatin; Naphthalenes; Neomycin; Niacin; Pentanoic Acids; Phenotype; Probucol | 1986 |
Treatment of hypercholesterolemia.
Topics: Animals; Cholestyramine Resin; Clofibrate; Colestipol; Cricetinae; Dogs; Drug Therapy, Combination; Female; Gemfibrozil; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Mice; Middle Aged; Neomycin; Niacin; Pentanoic Acids; Pregnancy; Probucol; Rats | 1986 |
The diagnosis and management of hyperlipidemia.
Topics: Adolescent; Adult; Child; Child, Preschool; Cholesterol; Cholestyramine Resin; Chylomicrons; Clofibrate; Colestipol; Coronary Disease; Dextrothyroxine; Dietary Fats; Gemfibrozil; Humans; Hyperlipidemia, Familial Combined; Hyperlipidemias; Hyperlipoproteinemia Type I; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type III; Hyperlipoproteinemia Type IV; Hyperlipoproteinemia Type V; Lipoproteins; Lipoproteins, LDL; Neomycin; Niacin; Pentanoic Acids; Probucol; Receptors, LDL; Triglycerides | 1986 |
Severe hypoalphalipoproteinemia induced by a combination of probucol and clofibrate.
Topics: Apolipoproteins; Cholesterol, HDL; Clofibrate; Drug Interactions; Humans; Hypolipoproteinemias; Lipids; Lipoproteins; Lipoproteins, HDL; Middle Aged; Phenols; Probucol; Time Factors | 1986 |
Hypolipidemic drugs.
Topics: Aminosalicylic Acids; Androgens; Bile Acids and Salts; Butyrates; Cellulose; Cholestyramine Resin; Clofibrate; Contraceptives, Oral; Female; Gonadal Steroid Hormones; Halofenate; Humans; Hyperlipidemias; Hypolipidemic Agents; Intestinal Absorption; Lignin; Lipid Metabolism; Lipid Mobilization; Male; Nafenopin; Neomycin; Nicotinic Acids; Oxandrolone; Probucol; Progestins; Sitosterols; Sterols; Thyroxine; Triglycerides | 1973 |
[Pharmacology of probucol. I].
Topics: Adult; Aged; Animals; Anticholesteremic Agents; Chemical Phenomena; Chemistry; Cholesterol; Clofibrate; Fatty Acids, Nonesterified; Humans; Hypercholesterolemia; Hyperlipoproteinemias; Lipoproteins, LDL; Liver; Macaca fascicularis; Middle Aged; Phenols; Phospholipids; Probucol; Rabbits; Rats; Saimiri; Triglycerides | 1984 |
[Pharmacologic therapy of atherosclerosis (I). Current possibilities].
Topics: Anticholesteremic Agents; Arteriosclerosis; Cholesterol; Clofibrate; Clofibric Acid; Fenofibrate; Gemfibrozil; Glycosaminoglycans; Humans; Ion Exchange Resins; Lipoproteins; Nicotinic Acids; Pentanoic Acids; Probucol | 1983 |
Recommendations for treatment of hyperlipidemia in adults. A joint statement of the Nutrition Committee and the Council on Arteriosclerosis.
Topics: Cholesterol; Clofibrate; Coronary Disease; Female; Gemfibrozil; Humans; Hypercholesterolemia; Hyperlipidemias; Hyperlipoproteinemia Type IV; Hyperlipoproteinemias; Lactation; Lipoproteins; Lovastatin; Naphthalenes; Niacin; Pentanoic Acids; Pregnancy; Pregnancy Complications; Probucol; Tangier Disease; Triglycerides | 1984 |
[Diagnosis and treatment of primary hyperlipidemias].
Topics: Cholesterol; Cholestyramine Resin; Clofibrate; Diagnosis, Differential; Drug Therapy, Combination; Female; Humans; Hyperlipidemia, Familial Combined; Male; Nicotinic Acids; Probucol; Triglycerides | 1982 |
Hyperlipidemia: perspectives in diagnosis and treatment.
Topics: Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Coronary Disease; Diet, Fat-Restricted; Diet, Reducing; Exercise; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Niacin; Probucol; Risk; Triglycerides | 1995 |
Methods and endpoint issues in clinical development of lipid-acting agents with pleiotropic effects.
Topics: Animals; Clofibrate; Drug Evaluation; Drug Evaluation, Preclinical; Drugs, Investigational; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Legislation, Drug; Probucol | 1998 |
4 trial(s) available for clofibrate and probucol
Article | Year |
---|---|
Long-term use of probucol in the multifactorial primary prevention of vascular disease.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Cerebrovascular Disorders; Cholesterol, HDL; Clinical Trials as Topic; Clofibrate; Coronary Disease; Diuretics; Drug Therapy, Combination; Humans; Hyperlipidemias; Hypertension; Male; Middle Aged; Obesity; Phenols; Probucol; Risk; Smoking Prevention; Time Factors | 1986 |
Lipid lowering effects on cardiovascular morbidity and mortality. Clinical evidence and therapeutic guidelines.
Topics: Cholesterol; Cholestyramine Resin; Clinical Trials as Topic; Clofibrate; Coronary Disease; Follow-Up Studies; Gemfibrozil; Humans; Hypolipidemic Agents; Lipoproteins; Male; Probucol; Triglycerides | 1988 |
[Effect of probucol on serum cholesterol concentration in primary hyperlipoproteinemia].
Topics: Adult; Aged; Cholesterol; Clinical Trials as Topic; Clofibrate; Female; Humans; Hyperlipoproteinemia Type II; Male; Middle Aged; Phenols; Probucol | 1982 |
Effect of long-term antihypertensive and hypolipidemic treatment on high density lipoprotein cholesterol and apolipoproteins A-I and A-II.
Topics: Antihypertensive Agents; Apolipoproteins; Body Weight; Cholesterol; Clofibrate; Humans; Hyperlipoproteinemia Type IV; Hypolipidemic Agents; Lipoproteins, HDL; Long-Term Care; Male; Probucol; Triglycerides | 1980 |
53 other study(ies) available for clofibrate and probucol
Article | Year |
---|---|
Hypolipidemic arylthioalkanoic acids.
Topics: Animals; Carboxylic Acids; Cholesterol; Hypolipidemic Agents; Liver; Male; Organ Size; Rats; Structure-Activity Relationship; Sulfides; Triglycerides | 1977 |
Synthesis and biological activity of new HMG-CoA reductase inhibitors. 3. Lactones of 6-phenoxy-3,5-dihydroxyhexanoic acids.
Topics: Animals; Anticholesteremic Agents; Caproates; Carcinoma, Hepatocellular; Cholesterol; Dogs; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lactones; Liver; Liver Neoplasms; Lovastatin; Male; Molecular Structure; Rabbits; Rats; Structure-Activity Relationship; Tumor Cells, Cultured | 1991 |
Studies on hindered phenols and analogues. 1. Hypolipidemic and hypoglycemic agents with ability to inhibit lipid peroxidation.
Topics: Animals; Hypoglycemic Agents; Hypolipidemic Agents; Lipid Peroxidation; Male; Mice; Mice, Inbred BALB C; Phenols; Rats; Structure-Activity Relationship | 1989 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
An overview of the biochemical pharmacology of probucol.
Topics: Animals; Aspartate Aminotransferases; Bile Acids and Salts; Catalase; Cholesterol; Clofibrate; Glucose-6-Phosphatase; Glutamate Dehydrogenase; Haplorhini; L-Lactate Dehydrogenase; Liver; Liver Glycogen; Macaca fascicularis; Male; Mice; Phenols; Probucol; Rats; Sterols | 1977 |
Drug management of hypercholesterolemia.
Topics: Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Humans; Hypercholesterolemia; Nicotinic Acids; Probucol; Sitosterols | 1979 |
Hypolipidemic drugs.
Topics: Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Humans; Hyperlipidemias; Lipoproteins; Nicotinic Acids; Probucol | 1978 |
[Treatment of hyperlipidemia].
Topics: Blood Component Removal; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Coronary Disease; Dietary Fiber; Energy Intake; Female; Humans; Hyperlipidemias; Male; Niceritrol; Pravastatin; Probucol | 1992 |
Choice of cholesterol-lowering drugs.
Topics: Anticholesteremic Agents; Cholestyramine Resin; Clofibrate; Colestipol; Fish Oils; Gemfibrozil; Humans; Lovastatin; Neomycin; Niacin; Probucol | 1991 |
Comparative studies on the influence of different fibrates on serum lipoproteins in endogenous hyperlipoproteinaemia.
Topics: Adult; Aged; Bezafibrate; Cholesterol; Clofibrate; Clofibric Acid; Colestipol; Female; Fenofibrate; Gemfibrozil; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Lipoproteins; Male; Middle Aged; Probucol | 1991 |
Concomitant induction of cytosolic but not microsomal epoxide hydrolase with peroxisomal beta-oxidation by various hypolipidemic compounds.
Topics: Animals; Aspirin; Clofibrate; Cytosol; Dose-Response Relationship, Drug; Enzyme Induction; Epoxide Hydrolases; Fatty Alcohols; Fenofibrate; Hepatomegaly; Hypolipidemic Agents; Imidazoles; Liver; Male; Microbodies; Microsomes, Liver; Oxidation-Reduction; Palmitoyl-CoA Hydrolase; Probucol; Rats; Rats, Inbred F344 | 1987 |
Biological properties of pancreatic elastase in relation to atherosclerotic disease.
Topics: Animals; Antacids; Arteriosclerosis; Calcium; Citrates; Citric Acid; Clofibrate; Diet, Atherogenic; Endothelium, Vascular; Erythrocyte Deformability; Fibrinolytic Agents; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Pancreas; Pancreatic Elastase; Platelet Aggregation Inhibitors; Probucol; Rats; Rats, Inbred Strains; Swine; Vitamin D | 1988 |
A little more information about aggravation of probucol-induced HDL-reduction by clofibrate.
Topics: Adult; Aged; Bezafibrate; Cholesterol, HDL; Clofibrate; Drug Interactions; Drug Therapy, Combination; Female; Humans; Lipoproteins, HDL; Male; Middle Aged; Phenols; Probucol | 1988 |
Medical management of hyperlipidemia and the role of probucol.
Topics: Adult; Arteriosclerosis; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Colestipol; Female; Gemfibrozil; Humans; Hyperlipidemias; Hyperlipoproteinemia Type II; Hyperlipoproteinemias; Hypolipidemic Agents; Male; Middle Aged; Niacin; Pentanoic Acids; Phenols; Probucol; Risk | 1986 |
Rational drug therapy of the hyperlipoproteinemias, Part II.
Topics: Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Female; Fish Oils; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemias; Hypolipidemic Agents; Male; Neomycin; Niacin; Pentanoic Acids; Probucol | 1986 |
Current pharmacologic treatment of elevated serum cholesterol.
Topics: Adult; Anticholesteremic Agents; Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Colestipol; Drug Tolerance; Female; Gemfibrozil; Humans; Hypercholesterolemia; Hyperlipidemias; Hyperlipoproteinemia Type II; Lovastatin; Male; Middle Aged; Naphthalenes; Neomycin; Niacin; Pentanoic Acids; Probucol; Simvastatin; Triglycerides | 1987 |
Adverse effects of the treatment for hyperlipidemia.
Topics: Anion Exchange Resins; Anticholesteremic Agents; Bibliographies as Topic; Clofibrate; Diet; Drug Therapy, Combination; Gemfibrozil; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Neomycin; Niacin; Pentanoic Acids; Physical Exertion; Probucol; Risk | 1986 |
Effects of some hypolipidemic agents on biochemical values and hepatic peroxisomal enzymes in rats: comparison of probucol, CGA, KCD-232, MLM-160, AL-369 and clinofibrate with clofibrate.
Topics: Animals; Cell Division; Clofibrate; Glycolates; Hypolipidemic Agents; Lipids; Liver; Liver Neoplasms, Experimental; Male; Microbodies; Nicotinic Acids; Phenoxyacetates; Probucol; Rats; Rats, Inbred Strains | 1987 |
Effects of probucol on xanthomata regression in familial hypercholesterolemia.
Topics: Achilles Tendon; Adolescent; Adult; Aged; Anticholesteremic Agents; Child; Child, Preschool; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Drug Therapy, Combination; Female; Humans; Hyperlipoproteinemia Type II; Lovastatin; Male; Middle Aged; Naphthalenes; Phenols; Plasmapheresis; Probucol; Xanthomatosis | 1986 |
Addition to labeling of cholestyramine.
Topics: Cholestyramine Resin; Clofibrate; Diet Therapy; Drug Labeling; Gemfibrozil; Humans; Hypolipidemic Agents; Niacin; Pentanoic Acids; Probucol; Thyroxine; United States; United States Food and Drug Administration | 1985 |
Lipid-lowering drugs.
Topics: Anticholesteremic Agents; Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Gemfibrozil; Humans; Hypolipidemic Agents; Lipoproteins; Neomycin; Niacin; Pentanoic Acids; Probucol; Triglycerides | 1985 |
Plasma carnitine and lipid-lowering drugs.
Topics: Carnitine; Cholesterol, HDL; Clofibrate; Female; Humans; Hyperlipidemia, Familial Combined; Hyperlipidemias; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Male; Probucol; Triglycerides | 1985 |
Effect of probucol on triton induced hyperlipidemias in CFY rats.
Topics: Animals; Cholesterol; Clofibrate; Hyperlipidemias; Hypolipidemic Agents; Male; Phenols; Polyethylene Glycols; Probucol; Rats; Triglycerides | 1985 |
[New derivatives of clofibrate and probucol. Preliminary study of their hypolipemic activity].
Topics: Animals; Chemical Phenomena; Chemistry; Clofibrate; Hyperlipidemias; Hypolipidemic Agents; Male; Mice; Mice, Inbred ICR; Phenols; Polyethylene Glycols; Probucol; Rats; Rats, Inbred Strains | 1985 |
Effects of clofibrate, cholestyramine, zanchol, probucol, and AOMA feeding on hepatic and intestinal cholesterol metabolism and on biliary lipid secretion in the rat.
Topics: Animals; Anticholesteremic Agents; Bile; Butyrates; Cholesterol; Cholestyramine Resin; Clofibrate; Female; Fluorenes; Intestines; Lipid Metabolism; Liver; Polymers; Probucol; Rats; Succinates | 1980 |
Influence of clofibrate, bile-sequestering agents and probucol on high-density lipoprotein levels.
Topics: Bile Acids and Salts; Clofibrate; Gemfibrozil; Humans; Hypolipidemic Agents; Lipoproteins; Lipoproteins, HDL; Nicotinic Acids; Pentanoic Acids; Phenols; Probucol | 1983 |
Hyperlipidemia: reducing the chances of cardiovascular disease.
Topics: Cholesterol; Cholestyramine Resin; Clofibrate; Coronary Disease; Gemfibrozil; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Pentanoic Acids; Probucol; Triglycerides | 1984 |
Effects of clofibrate, bezafibrate, fenofibrate and probucol on plasma lipolytic enzymes in normolipaemic subjects.
Topics: Adult; Bezafibrate; Cholesterol; Clofibrate; Fenofibrate; Humans; Hypolipidemic Agents; Lipase; Lipolysis; Lipoprotein Lipase; Male; Phosphatidylcholine-Sterol O-Acyltransferase; Probucol; Triglycerides | 1983 |
Probucol-lipid pharmacology.
Topics: Animals; Arteriosclerosis; Cholesterol; Clofibrate; Feces; Haplorhini; Humans; Lipid Metabolism; Lipids; Macaca fascicularis; Mice; Phenols; Probucol; Rabbits; Rats; Steroids | 1982 |
Pharmacologic therapy for the hyperlipidemic patient.
Topics: Bile Acids and Salts; Clofibrate; Dextrothyroxine; Humans; Hyperlipidemias; Hypolipidemic Agents; Niacin; Probucol | 1983 |
Effect of probucol on serum lipoprotein levels in normal and dyslipoproteinemic mice.
Topics: Animals; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Clofibrate; Dose-Response Relationship, Drug; Hypercholesterolemia; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Mice; Phenols; Probucol | 1981 |
Experience with probucol in the treatment of hypercholesterolemia.
Topics: Cholesterol; Clofibrate; Clofibric Acid; Humans; Hypercholesterolemia; Lipoproteins; Male; Middle Aged; Patient Compliance; Phenols; Probucol | 1982 |
The mechanism of action of lipid-lowering drugs.
Topics: Cholestyramine Resin; Chylomicrons; Clofibrate; Fatty Acids; Hypolipidemic Agents; Lipid Metabolism; Lipolysis; Lipoprotein Lipase; Lipoproteins; Nicotinic Acids; Probucol | 1982 |
[Comparative effect of probucol and clofibrate in patients with primary hypercholesterolemia].
Topics: Adult; Clofibrate; Female; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Male; Middle Aged; Phenols; Probucol | 1982 |
Lipid-lowering drugs.
Topics: Cholestyramine Resin; Clofibrate; Colestipol; Humans; Hypolipidemic Agents; Neomycin; Nicotinic Acids; Probucol | 1980 |
Drug treatment of hyperlipidemia.
Topics: Adolescent; Adult; Child; Cholesterol; Cholestyramine Resin; Clofibrate; Colestipol; Humans; Hyperlipidemias; Middle Aged; Neomycin; Nicotinic Acids; Probucol | 1980 |
Effect of probucol on cholesterol metabolism in the rat.
Topics: Animals; Body Weight; Cholesterol; Cholesterol 7-alpha-Hydroxylase; Clofibrate; Hydroxymethylglutaryl CoA Reductases; Hyperlipoproteinemias; Liver; Male; Organ Size; Phenols; Probucol; Rats | 1980 |
Comparative ultrastructural study of rat hepatocytes after treatment with the hypolipidemic agents probucol, clofibrate, and fenofibrate.
Topics: Animals; Cholesterol; Clofibrate; Female; Liver; Male; Phenols; Probucol; Rats | 1980 |
[Hypolipidaemic agents (author's transl)].
Topics: Animals; Chemical Phenomena; Chemistry; Cholesterol; Cholestyramine Resin; Clofibrate; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipoproteins; Nicotinic Acids; Probucol | 1980 |
[Probucol: chemical structure, physical properties and assay methods (author's transl)].
Topics: Chemical Phenomena; Chemistry; Chromatography, Gas; Chromatography, High Pressure Liquid; Clofibrate; Humans; Phenols; Probucol; Spectrophotometry, Ultraviolet | 1980 |
[The effects of probucol in man (author's transl)].
Topics: Anticholesteremic Agents; Arteriosclerosis; Bile; Clofibrate; Electrocardiography; Heart; Humans; Hyperlipoproteinemia Type II; Phenols; Probucol | 1980 |
[Comparative study of the effects of probucol, fenofibrate and clofibrate on liver ultrastructure in rats (author's transl)].
Topics: Animals; Body Weight; Clofibrate; Fenofibrate; Hypolipidemic Agents; Lipids; Liver; Microbodies; Microscopy, Electron; Phenols; Probucol; Propionates; Rats | 1980 |
The effects of probucol and clofibrate alone and in combination on hepatic cholesterol metabolism in the male rat.
Topics: Animals; Body Weight; Cholesterol; Clofibrate; Cytosol; Lipid Metabolism; Lipids; Liver; Male; Microsomes, Liver; Organ Size; Probucol; Rats; Rats, Wistar; Sterol Esterase; Sterol O-Acyltransferase | 1995 |
Inhibition of neutral cholesterol ester hydrolase in rat liver by fibric acids and probucol in vitro.
Topics: Animals; Bezafibrate; Clofibrate; Cytosol; Kinetics; Liver; Male; Microsomes, Liver; Probucol; Rats; Sterol Esterase | 1994 |
Peroxisome enzyme modification and oxidative stress in rat by hypolipidemic and antiinflammatory drugs.
Topics: Acetyl-CoA C-Acetyltransferase; Acyl-CoA Oxidase; Animals; Anti-Inflammatory Agents; Aspirin; Base Sequence; Brain; Catalase; Clofibrate; Diflunisal; Hypolipidemic Agents; Lipid Peroxidation; Liver; Male; Microbodies; Molecular Sequence Data; Oxidative Stress; Oxidoreductases; Probucol; Rats; Rats, Wistar; RNA, Messenger; Superoxide Dismutase; Zinc | 1994 |
The effect of probucol and clofibrate on hepatic cholesterol metabolism.
Topics: Animals; Cholesterol; Clofibrate; Liver; Male; Probucol; Rats; Rats, Wistar; Sterol Esterase; Sterol O-Acyltransferase | 1994 |
Effects of clofibrate, phthalates and probucol on ubiquinone levels.
Topics: Animals; Brain; Cholesterol; Chromatography, High Pressure Liquid; Clofibrate; Diet; Diethylhexyl Phthalate; Dolichols; Liver; Male; Mevalonic Acid; Muscles; Myocardium; Oxidation-Reduction; Probucol; Rats; Rats, Sprague-Dawley; Ubiquinone | 1994 |
Use of a human microvascular endothelial cell line as a model system to evaluate cholesterol uptake.
Topics: Biological Transport; Cells, Cultured; Cholesterol; Cholestyramine Resin; Clofibrate; Endothelium, Vascular; Gemfibrozil; Humans; Models, Biological; Probucol; Tritium | 1993 |
Choice of cholesterol-lowering drugs.
Topics: Anticholesteremic Agents; Cholestyramine Resin; Clofibrate; Colestipol; Fish Oils; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Niacin; Probucol | 1993 |
Effects of hypolipidemic drugs on the expression of genes involved in high density lipoprotein metabolism in the rat.
Topics: Actins; Animals; Apolipoproteins; Cholestyramine Resin; Clofibrate; Fenofibrate; Gene Expression Regulation; Hypolipidemic Agents; Intestinal Mucosa; Lipid Metabolism; Lipoproteins, HDL; Liver; Lovastatin; Male; Niacin; Probucol; Rats; Rats, Wistar; Simvastatin | 1996 |
[Effect of F-1394, a potent and selective inhibitor of acyl-CoA:cholesterol acyltransferase (ACAT), on esterification of cholesterol and basolateral secretion of cholesteryl ester in Caco-2 cells].
Topics: Anilides; Anticholesteremic Agents; Caco-2 Cells; Cholesterol; Cholesterol Esters; Clofibrate; Cyclohexanes; Dioxanes; Esterification; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intestinal Mucosa; Phenylurea Compounds; Pravastatin; Probucol; Simvastatin; Sterol O-Acyltransferase | 1997 |